Long-acting antipsychotic medication, restraint and treatment in the management of acute psychosis

REFERENCES

• Amdisen A, Aaes-Jorgensen T, Thomsen N J, Madsen V T, Nielsen M S. Serum concentrations and clinical effects of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo. Psychopharmacology 1986; 90: 412–416
   Google Scholar
• Nyberg S, Farde L, Bartfai A, Halldin C. Central D2 receptor occupancy and the effects of zuclopenthixol acetate in humans. International Clinical Psychopharmacology 1995; 10: 221–227
   Google Scholar
• Farde L, Nordstrom A L, Wiesel F A, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Archives of General Psychiatry 1992; 49: 538–544
   Google Scholar
• Nordstrom A L, Farde L, Wiesel F A. et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects—a double-blind PET study of schizophrenic patients. Biological Psychiatry 1993; 33: 227–235
   Google Scholar
• Kapur S. A new framework for investigating antipsychotic action in humans: lessons from PETimaging. Molecular Psychiatry 1998; 3: 135–140
   Google Scholar
• Overall J E, Goreham D R. Brief Psychiatric Rating Scale. Psychological Reports 1962; 10: 799–812
   Google Scholar
• Balant L P, Balant-Gorgia A E, Eisele R, Reith B, Gex Fabry M, Garrone G. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo. Pharmacopsychiatry 1989; 22: 250–254
   Google Scholar
• Chakrayard S K, Muthu A, Muthu P K, Naik P, Pinto R. Zuclopenthixol acetate (5% in ‘Viscoleo’): single-dose treatment for acutely disturbed psychotic patients. Current Medical Research and Opinion 1990; 12: 58–65
   Google Scholar
• Amdisen A, Nielsen M S, Dencker S J. et al. Zuclopenthixol acetate in Viscoleo: a new drug formulation: an open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychosis including mania and exacerbation of chronic psychosis. Acta Psychiatrica Scandinavica 1987; 75: 99–107
   Google Scholar
• Baastrup P C, Alhfroors U G, Bjerkenstedt L. et al. A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis. Acta Psychiatrica Scandinavica 1993; 87: 48–58
   Google Scholar
• Chouinard G, Safadi G, Beauclair L. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Journal of Clinical Psychopharmacology 1994; 14: 377–384
   Google Scholar
• Coutinho E, Fenton M, Cambell C, Davis A. Mental Health Emergencies: details of studies of zuclopenthixol acetate are needed [letter]. British Medical Journal 1997; 315: 884
   Google Scholar
• Fenton M, Coutinho E, Campbell C. Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses. The Cochrane Library, Oxford 1998
   Google Scholar
• Remington G, Reed K, Voineskos G, Coulter K. A double-blind comparison of zuclopenthixol acetate and haloperidol in acutely psychotic patients [abstract]. Schizophrenia Research 1993; 9: 247
   Google Scholar
• Laurier C, Kennedy W, Lachaine J, Gariepy L, Tessier G. Economic evaluation of zuclopenthixol acetate compared with injectible haloperidol in schizophrenic patients with acute psychosis. Clinical Therapeutics 1997; 19: 316–329
   Google Scholar
• Walker Z, Seifert R. Violent incidents in a psychiatric intensive care unit. British Journal of Psychiatry 1994; 164: 826–828
   Google Scholar
• McGorry P D, Chanen A, McCarthy E, Van Riel R, McKenzie D, Singh B. Posttraumatic stress disorder following recent-onset psychosis. Journal of Nervous and Mental Disease 1991; 179: 253–258
   Google Scholar
• Jeffries J. Restraint or treatment? Protecting patient and provider. Canadian Psychiatric Association Bulletin 1998; 30: 51–52
   Google Scholar
• 1982, Youngberg v. Romeo. 102 Supreme Ct 2452, US
   Google Scholar
• Applebaum P S. The right to refuse treatment with antipsychotic medication: retrospect and prospect. American Journal of Psychiatry 1988; 145: 413–419
   Google Scholar
• Rogers v. Okin (Rogers v. Macht) Civil action no. 785—1610T in the U.S. District Court for the District of Massachusetts
   Google Scholar
• Soloff P H. Seclusion and restraint. Assaults within psychiatric facilities, J R Lion, W H Reid. Grune and Stratton, New York 1983; 241–264
   Google Scholar
• Rosen H, DiGiacomo J N. The role of physical restraint in the treatment of psychiatric illness. Journal of Clinical Psychiatry 1978; 39: 228–223
   Google Scholar
• Soloff P H, Turner S M. Patterns of seclusion. Journal of Nervous and Mental Disease 1981; 169: 37–44
   Google Scholar
• Binder R L. The use of seclusion on an inpatient crisis intervention unit. Hospital and Community Psychiatry 1979; 30: 266–269
   Google Scholar